Make sure to sign up for an account today for exclusive coupons and free shipping on orders over $75!
Maximum quantity allowed is 999
CAS RN: 1082949-68-5 | Product Number: L0463
LY-2584702 Tosylate
![LY-2584702 Tosylate No-Image](/medias/Tci-440-L0463.jpg?context=bWFzdGVyfHJvb3R8MjM5NDh8aW1hZ2UvanBlZ3xhR0pqTDJnME9DODVOVEF6TURBMU1qYzRNak00TDFSamFTMDBOREJmVERBME5qTXVhbkJufDMzN2FjZTFkNTZmNWMxZDM1OTVhZjRiZmVhNTk2NzVhNDBhOGRlYjRkNjcyZWVjOWYwZTMxNzFkMDE5MzY0NWU)
Purity: >95.0%(HPLC)
- 4-[4-[4-[4-Fluoro-3-(trifluoromethyl)phenyl]-1-methyl-1H-imidazol-2-yl]piperidin-1-yl]-1H-pyrazolo[3,4-d]pyrimidine 4-Methylbenzenesulfonate
Size | Unit Price | Philadelphia, PA | Portland, OR | Japan* | Quantity |
---|---|---|---|---|---|
10MG |
$261.00
|
Contact Us | Contact Us | ≥100 |
|
* Items in stock locally ship in 1-2 business days. Items from Japan stock are able to ship from a US warehouse within 2 weeks. Please contact TCI for lead times on items not in stock. Excludes regulated items and items that ship on ice.
* To send your quote request for bulk quantities, please click on the "Request Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | L0463 |
Purity / Analysis Method | >95.0%(HPLC) |
Molecular Formula / Molecular Weight | C__2__1H__1__9F__4N__7·C__7H__8O__3S = 617.62 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Refrigerated (0-10°C) |
Store Under Inert Gas | Store under inert gas |
Condition to Avoid | Air Sensitive,Heat Sensitive |
CAS RN | 1082949-68-5 |
Reaxys Registry Number | 18671815 |
MDL Number | MFCD29054739 |
Appearance | White to Yellow powder to crystal |
Purity(HPLC) | min. 95.0 area% |
Purity(qNMR) | min. 93.0 % |
NMR | confirm to structure |
HS Number | 2933.59.7000 |
References
- A phase Ib trial of LY2584702 tosylate, a p70 S6 inhibitor, in combination with erlotinib or everolimus in patients with solid tumours
- A phase I trial of LY2584702 tosylate, a p70 S6 kinase inhibitor, in patients with advanced solid tumours
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.